Halozyme Therapeutics shares owned by Gotham Asset Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Gotham Asset Management
from 13F filings
Historical chart of Gotham Asset Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Gotham Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Halozyme Therapeutics by Gotham Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $19M | 253k | 73.34 |
| 2025-06-30 | $3.5M | 68k | 52.02 |
| 2025-03-31 | $2.1M | 33k | 63.81 |
| 2024-12-31 | $2.3M | 47k | 47.81 |
| 2024-09-30 | $2.5M | 43k | 57.24 |
| 2024-06-30 | $1.5M | 28k | 52.36 |
| 2024-03-31 | $1.7M | 42k | 40.68 |
| 2023-12-31 | $3.6M | 98k | 36.96 |
| 2023-09-30 | $1.6M | 42k | 38.20 |
| 2023-06-30 | $1.3M | 36k | 36.07 |
| 2023-03-31 | $1.7M | 44k | 38.19 |
| 2022-12-31 | $1.6M | 27k | 56.90 |
| 2022-09-30 | $1.2M | 30k | 39.54 |
| 2022-06-30 | $1.3M | 31k | 44.01 |
| 2022-03-31 | $1.6M | 39k | 39.87 |
| 2021-12-31 | $1.8M | 45k | 40.21 |
| 2021-09-30 | $953k | 23k | 40.67 |
| 2021-06-30 | $1.6M | 34k | 45.41 |
| 2021-03-31 | $1.9M | 46k | 41.68 |
| 2020-12-31 | $907k | 21k | 42.70 |
| 2020-09-30 | $549k | 21k | 26.28 |
| 2020-06-30 | $560k | 21k | 26.82 |
| 2020-03-31 | $319k | 18k | 17.99 |
| 2019-09-30 | $207k | 13k | 15.52 |
| 2019-06-30 | $223k | 13k | 17.19 |
| 2018-06-30 | $1.0M | 62k | 16.86 |
| 2018-03-31 | $2.3M | 116k | 19.59 |
| 2016-06-30 | $296k | 34k | 8.63 |
| 2015-09-30 | $389k | 29k | 13.43 |
| 2015-06-30 | $829k | 37k | 22.59 |